Therefore, the co-expression of CD44 & CD133 has been extensively utilized for the isolation and identification of cancer stem cells in a variety of malignant tumors, including but not limited to colorectal cancer, non-small cell lung cancer, ovarian cancer, prostate cancer, and gallbladder cancer (7). This evidence concerns the gene PROM1 and cancer.